Market Cap ₹10 Cr.
Stock P/E 5.5
P/B 0.7
Current Price ₹26.4
Book Value ₹ 39.1
Face Value 10
52W High ₹87.4
Dividend Yield 0%
52W Low ₹ 23.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|
Net Sales | 1 | 7 | 14 | 14 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 1 | 7 | 14 | 14 | |
Total Expenditure | 2 | 7 | 11 | 11 | |
Operating Profit | -0 | 0 | 3 | 3 | |
Interest | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | -0 | -0 | 2 | 2 | |
Provision for Tax | -0 | 0 | 1 | 1 | |
Profit After Tax | -0 | -0 | 2 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | -0 | -0 | 2 | 2 | |
Adjusted Earnings Per Share | -30.8 | -14.9 | 1.4 | 6.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 141% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -53% | NA% | NA% | NA% |
ROE Average | 40% | 39% | 22% | 22% |
ROCE Average | 45% | 42% | 21% | 21% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Shareholder's Funds | 1 | 0 | 3 | 5 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | -0 | -0 | -0 | 0 |
Total Current Liabilities | 0 | 1 | 7 | 2 |
Total Liabilities | 1 | 2 | 10 | 8 |
Fixed Assets | 0 | 0 | 0 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 |
Total Current Assets | 0 | 1 | 10 | 7 |
Total Assets | 1 | 2 | 10 | 8 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 1 | 1 |
Cash Flow from Operating Activities | -0 | -1 | -1 | 1 |
Cash Flow from Investing Activities | -0 | -0 | -0 | -0 |
Cash Flow from Financing Activities | 1 | 1 | 1 | -0 |
Net Cash Inflow / Outflow | 0 | 0 | 1 | 0 |
Closing Cash & Cash Equivalent | 0 | 1 | 1 | 1 |
# | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Earnings Per Share (Rs) | -30.8 | -14.86 | 1.43 | 6.85 |
CEPS(Rs) | -29.74 | -12.56 | 1.46 | 7.07 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 100.36 | 85.5 | 2.73 | 20.38 |
Core EBITDA Margin(%) | -15.62 | 0.23 | 18.11 | 18.65 |
EBIT Margin(%) | -15.96 | 0.08 | 18.04 | 18.32 |
Pre Tax Margin(%) | -16.05 | -0.47 | 16.94 | 17.29 |
PAT Margin (%) | -11.79 | -1.2 | 13 | 12.78 |
Cash Profit Margin (%) | -11.39 | -1.01 | 13.2 | 13.2 |
ROA(%) | -32.29 | -8.06 | 31.14 | 19.73 |
ROE(%) | -30.68 | -15.99 | 92.33 | 40.4 |
ROCE(%) | -41.53 | 0.52 | 81.28 | 45.46 |
Receivable days | 0 | 24.73 | 100.98 | 98.41 |
Inventory Days | 56.99 | 14.87 | 18.27 | 67.76 |
Payable days | 2.58 | 0.27 | 107.57 | 175.62 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | -0.13 | 0.07 | 0.19 | 0.18 |
EV/Core EBITDA(x) | 0.83 | 26.92 | 1.02 | 0.95 |
Net Sales Growth(%) | 0 | 374.32 | 100.07 | -2.11 |
EBIT Growth(%) | 0 | 102.27 | 0 | -0.58 |
PAT Growth(%) | 0 | 51.74 | 2266.99 | -3.78 |
EPS Growth(%) | 0 | 51.74 | 109.65 | 377.23 |
Debt/Equity(x) | 0 | 2.09 | 0.37 | 0.21 |
Current Ratio(x) | 13 | 1.28 | 1.48 | 3 |
Quick Ratio(x) | 6.36 | 0.96 | 1.33 | 1.29 |
Interest Cover(x) | -179.69 | 0.14 | 16.4 | 17.79 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Sep 2024 | Mar 2025 |
---|---|---|
Promoter | 49.98 | 49.98 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 50.02 | 50.02 |
Others | 0 | 0 |
Total | 100 | 100 |
# | Sep 2024 | Mar 2025 |
---|---|---|
Promoter | 0.18 | 0.18 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 0.18 | 0.18 |
Others | 0 | 0 |
Total | 0.36 | 0.36 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About